Linked Life Data

9923577

Source:http://linkedlifedata.com/resource/pubmed/id/9923577

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9-10
pubmed:dateCreated
1999-3-26
pubmed:abstractText
The potent CYP1A2 inhibitor fluvoxamine has recently been shown also to be an effective inhibitor of the CYP2C19-mediated metabolism of the antimalarial drug proguanil in vivo. The purpose of the present study was to confirm this interaction in vitro.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0031-6970
pubmed:author
pubmed:issnType
Print
pubmed:volume
54
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
735-40
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed:articleTitle
Fluvoxamine inhibits the CYP2C19-catalysed metabolism of proguanil in vitro.
pubmed:affiliation
Department of Clinical Pharmacology, Institute of Medical Biology, Odense University, Denmark. bb.rasmussen@winsloew.ou.dk
pubmed:publicationType
Journal Article, In Vitro, Research Support, Non-U.S. Gov't